The present inventions relates generally to medical devices. More specifically, the present inventions relate to stents. The stents may find particular use in intravascular procedures in general, and in cardiovascular procedures in particular, as well as other areas.
Stents are well known to those skilled in the biomedical arts. In particular, stents are commonly used in cardiovascular applications. Stents have gained increasing acceptance, particularly when used in conjunction with minimally invasive procedures such as angioplasty. Blockages of the coronary arteries may result from various causes, including plaque build-up, and stenosed or thrombosed vessel regions. The vessel regions thus partially occluded can cause angina and, when totally occluded, myocardial infarction, and even death. Minimally invasive procedures such as balloon angioplasty have been used to dilate such blocked vessel regions, thereby at least partially restoring patent vessel lumens.
In a significant percentage of cases, a stenosed, then dilated vessel region may narrow after treatment over a period ranging from days to months. This re-narrowing or restenosis, limits the efficacy of the angioplasty procedures, may require further angioplasty, or can lead to myocardial infarction and even death.
Cerebral blockages are typically caused by a thrombus. The thrombus can form or lodge in a cerebral artery, preventing brain regions downstream from receiving perfusing blood flow. The loss of oxygen can rapidly cause brain death in the affected brain regions if the blockage is not soon treated. The cerebral arteries are generally smaller and more tortuous than the corresponding coronary arteries. The required timing and difficult vessel characteristics make reaching and treating the thrombus to prevent brain cell death a most difficult task. The narrow cerebral vessels make placing stents within the brain very difficult using current stents and stent delivery systems. Microcatheters are currently used to infuse drugs into cerebral blood vessels. The microcatheters are typically not greater than about 4 Fr. (1⅓ mm.) in outer diameter, currently being generally unsuitable for delivery of cerebral stents.
Stents have been extensively utilized in an attempt to prevent or limit restenosis. Stents are typically tubular devices delivered to the stenosed and dilated site. The stents can be expanded into place against the treated region walls, hopefully preventing restenosis and further narrowing at the stented location. Stents are often formed of metal, commonly stainless steel or Nitinol. The stents can be open walled structures formed from lattice-like cages, spiral wire structures, braided structures, and helically wound and counterwound structures. Stents can be self-expanding, designed to expand radially when distally advanced from a restraining delivery catheter. Stents can also be balloon-expandable. Balloon-expandable stents can be positioned and then expanded from within using a stent delivery balloon and/or an angioplasty balloon.
A typical stent delivery device includes a stent constrained within an outer delivery sheath extending over the length of the stent. When the device is advanced to the target site, the outer sheath is proximally retracted and/or the stent is distally advanced from within the sheath to the target site. The delivery sheaths may work as intended, but do add bulk to the distal end of the delivery device. In particular, the delivery sheath adds at least one additional layer surrounding the stent. The delivery sheaths are generally cylindrical in nature and extend over the entire length of the stent. The stent can act to reinforce the outer sheath. The delivery sheath and enclosed stent thus act to form a rather rigid composite structure that is not as able to bend and traverse the tortuous vessel regions often found in the human body. The composite structure is thus not as flexible as either the stent or sheath alone would be in traversing these passages.
The added bulk and profile or cross-sectional area of the delivery device can thus act to restrict the use of such stents to larger vessels. In particular, this may leave smaller vessels unreachable and untreatable. Sites requiring treatment disposed on the distal side of a tortuous curve may also be unreachable and untreatable.
In use, some currently available stents and delivery systems also have another limitation. For self-expanding stents, stent placement is often imprecise. The placed or final stent length is related to the final stent diameter that is related to the vessel diameter. Within a vessel, the diameter is not always precisely known, and can vary over the region to be stented. It may be nearly impossible to predict the final stent length before the stent is fully expanded in the vessel.
The difficulty in accurate stent placement can become an issue in stenting a vessel ostium. It is often desirable to place a stent precisely at the ostium of a vessel, especially in coronary and renal vessels. If the stent is positioned too proximal, the stent extends into the trunk line, and can cause flow disturbance. If the stent is positioned too distal, the disease at the ostium is not treated. Self-expanding stent delivery systems typically deploy the stent from distal to proximal, with the distal stent end being advanced distal-most. In particular, a self-expanding stent may be advanced while disposed within a delivery sheath. When the sheath distal end is in position, the sheath can be retracted, allowing the accurately placed stent distal end to expand first. The proximal end of the stent can vary depending on the vessel diameter. In order to accurately place the stent proximal end, the treating physician thus needs to guess at the position to start stent deployment based on the assumed final stent length, so that the proximal end of the stent ends up at the precise ostial location desired.
What would be desirable are devices and methods for delivering stents to target vessel regions that do not require the added bulk of an external restraint or capture sleeve over the stent. Applicants believe that devices and methods not absolutely requiring a delivery sheath over the stent would allow smaller, more tortuous, and more distal vessels to be effectively treated.
The present inventions include devices and methods for delivering stents to target vessel regions within the body. Methods and devices for delivering everted stents are preferred and disclosed. One stent delivery assembly includes a delivery tube having a stent slidably disposed over the delivery tube distal region, and having the stent distal region everted over the delivery tube distal end, such that the stent distal end is tucked inside of the delivery tube distal end lumen. An elongate release member having a distal element can be slidably disposed within the delivery tube lumen. The release member distal element can be dimensioned relative to the surrounding delivery tube distal end inside diameter so as to form a tight fit between the release member distal element and the surrounding delivery tube. The stent distal region can be held by a friction or interference fit between the release member distal element and surrounding delivery tube walls. The stent is thus everted and reduced in outer diameter at the leading, everted distal end.
In one delivery device, the elongate release member is pulled from the proximal region, thereby proximally urging the release member distal element free of the stent distal end captured between the release member distal element and the surrounding delivery tube distal end. In such embodiments, the release member function may be served by an elongate string or wire having significant strength mainly in tension rather than compression. In another embodiment of the inventions, the elongate release member function is served by a shaft having sufficient strength in compression to distally urge the release member distal element by manipulating the release element proximal region, forcing the distal element from the surrounding delivery tube distal end, thereby freeing and unconstraining the stent distal region. In some embodiments, the delivery tube functionality is served by a delivery shaft having only the distal region being tubular in nature. In one such embodiment, the delivery shaft has a distal hoop or annular ring for surrounding and capturing the everted stent distal region within.
In use, the stent can be everted over the delivery tube or shaft, with the stent distal end everted and captured by the elongate release member. The everted stent, delivery shaft or tube, and release member can be advanced distally to a target vessel region to be stented. Once at the target region location, the everted and constrained stent may be freed of the delivery shaft or tube by the release member. The release member may be retracted proximally in some embodiments, and advanced distally in other embodiments, as previously discussed, to release the everted stent. Once released, the stent is free to expand radially and approach the surrounding vessel walls or blockage.
Self-expanding stents can be used in some embodiments of the inventions. The stents are preferably biased to radially expand when freed of the constraints of the delivery tube and release member. In other embodiments, balloon expandable stents are used, which can be expanded using inflatable balloon catheters or other stent delivery devices.
Some methods according to the present inventions can utilize a guide wire to facilitate advancement of a guide catheter or microcatheter to a location near the vessel region to be stented. The guide wire can be retracted, and the carried everted stent advanced by the release member and guide tube together through the guide catheter or microcatheter to the target region. In one method, the everted stent carried by the delivery tube and release member are advanced distally from the guide catheter to cross the target region, for example, a blood vessel stenosis. In another method, the microcatheter together with the everted stent carried by the delivery tube and release member are advanced through the stenosis or other blockage, followed by proximally retracting the microcatheter, leaving the everted stent to expand against the target region vessel or blockage walls. Once the everted stent is in location, the release member can be activated by advancing or retracting the member to free the everted stent.
Once unconstrained, the stent, for example, a self-expanding stent, may expand to approach the vessel walls or the blockage. In some embodiments, the release member may be advanced distally through the previously placed stent lumen to guarantee a minimal lumen through the stent and/or to act as a guide member for other devices to be passed through the now stented region. In one method, the delivery tube is advanced through the now stented region, which can act to further dilate the stent. In another method, the guide catheter or microcatheter can also be advanced through the now stented region, which can act to further dilate the stent. Thus, a succession of ever increasing diameter devices may be advanced through the stent after stent deployment in some methods. In another method, a balloon catheter is advanced through the now stented region followed by inflation of the balloon and concomitant dilation of the stent.
In another use of the present inventions, an everted porous stent carried by a delivery tube can be distally advanced through a thrombosed blood vessel region. A wire mesh or braided stent may be used. The everted stent can be released from the delivery tube to expand against the thrombus. The delivered stent can thus act to stabilize the thrombus. After stenting, the thrombus can be treated by infusing thrombolytic agents near the thrombus, through the walls of the porous stent. The stent can thus act to stabilize the thrombus, preventing large pieces from breaking off and being carried downstream during the thrombolysis.
Some embodiments of the present inventions have distally tapered delivery tubes having very small distal end profiles. In these embodiments, the release member distal element may be very small in profile as well. The limit of the distal profile in such devices may approach the lower size limit in gathering, everting, and compressing the distal region of the stent to be delivered. In these and other embodiments, the leading edge of the stent delivery device can be very benign and atraumatic due to the everted stent forming the distal-most leading edge of the device. Many embodiments of the device thus eliminate the absolute need for a delivery sheath or tube disposed about the stent, thereby eliminating one set of tube profiles from the device, making the distal region more flexible, smaller in profile, and able to reach even more distal and smaller diameter vessels which will benefit from treatment.
The following detailed description should be read with reference to the drawings, in which like elements in different drawings are numbered identically. The drawings, which are not necessarily to scale, depict selected embodiments and are not intended to limit the scope of the inventions. Several forms of inventions have been shown and described, and other forms will now be apparent to those skilled in art. It will be understood that embodiments shown in drawings and described above are merely for illustrative purposes, and are not intended to limit scope of the inventions as defined in the claims that follow.
Release member 24 may be seen, at distal end 42, to have an outside diameter D1 which closely approximates the inside diameter of delivery tube 22 in the distal region. Stent 26 may be seen gripped between release member distal end 42 and delivery tube 22. Stent 26, in some embodiments, may be biased to expand radially when unconstrained. As illustrated in
Microcatheters are well known devices, commonly used to deliver drugs to cerebral arteries. “Microcatheters”, as the term is used herein, is defined to be a tubular catheter having an outside diameter less than about 5 Fr. (1⅔ mm.). Microcatheters used with the present inventions preferably have an outside diameter between about 1.5 Fr. (½ mm.) and 4 Fr. (1⅓ mm), inclusive. Microcatheters preferably have a floppy distal region and tip, the distal region being more pliable and softer than the intermediate and proximal microcatheter regions.
In one method according to the present inventions, a guidewire is advanced distally through the vessel until the guidewire distal tip is across or proximally near vessel target region 80. Guide catheter or microcatheter 62 can then be advanced over the placed guidewire until microcatheter distal end 66 is disposed proximal of blockage 84. In some methods, the guidewire is now retracted proximally from microcatheter 62.
With microcatheter 62 in place, stent delivery device 20 may be advanced through microcatheter lumen 68 to a position within microcatheter 60 proximal of vessel target region 80. As may be seen from inspection of
With release member 24, delivery tube 22, and everted stent 26 in position, the release member, the delivery tube, and the captured, constrained and everted stent 26 may be distally advanced across the target site 80 having blockage 84. In some methods, the advancing of release member, delivery tube, and everted stent is accomplished while leaving guide catheter or microcatheter 62 positioned proximal of the vessel target site. In other methods, guide catheter or microcatheter 62 is advanced across target vessel region 80. In one method, microcatheter 62, everted stent 26, delivery tube 22, and release member 24 are all advanced together across target region 80. In this method, after microcatheter 62 and constrained, everted stent 26 are across target vessel region 80, microcatheter 62 can be proximally retracted, exposing the stent.
As may be seen from inspection of
Once everted stent 26 is at the desired location, the stent can be released from delivery tube 22. In one example of the inventions, release member 24 is urged proximally, thereby pulling the release member distal end proximally until release member distal end 42 is disposed proximally of everted stent distal end 47. Stent 26 may then expand further radially to embrace the surrounding vessel target region 80. In another example of the inventions, elongate release member 24 can be distally urged, thereby forcing release member distal end 42 distally from delivery tube 22, thereby releasing stent 26 from delivery tube 22. In embodiments having optional collar 51, the collar can be used to help push out the stent after release. Both distal and proximal movement of release member 24 can be accomplished by manipulating the proximally accessible portion of the release member. Stent 26 is then free to radially expand and retain its previous, non-everted shape.
It may be seen from inspection of
The distance between release member 24 and delivery tube 22 is indicated at D3 in
In one method according to the inventions, after stent 26 has been allowed to expand radially, this process may be assisted using parts of the device previously described. In embodiments where the release rod has sufficient strength in compression to be pushed, release member 24 may be advanced distally through deployed stent 26 to ensure that an initial clear flow passage exists through stent 26. Elongate release member 24 may be followed by distally advancing delivery tube 22 through deployed stent 26. In other methods, guide catheter or microcatheter 62 may be advanced through deployed stent 26, to further widen the already stented passage. These methods may also be employed to assist with eversion of the distal end of the released but incompletely deployed stent. In some methods, the delivery tube and release member may be retracted proximally, and an inflatable balloon catheter advanced to the now stented vessel site to further dilate the deployed stent by inflating the inflatable balloon disposed in the balloon catheter distal region.
Inspection of
Stents that may be used with the present inventions include self-expanding and balloon expandable stents, well known to those in the cardiovascular arts. Stents may be formed from many of the well known stent materials, including Nitinol, stainless steel, and polymers. The stents may be braided, knit, meshed, formed of non-woven wires, helically wound and helically counterwound. Stents according to the present inventions are preferably porous, wire, braided stents, with various embodiments having an average pore or inter-wire opening size of at least about 20 microns in one embodiment, and at least 50 microns in another embodiment. In a preferred embodiment the stent ends are coated with flexible adherent material to prevent unraveling of, for example, braided stents. Alternatively, the stent strands can be welded or otherwise fastened to one another to prevent unraveling during eversion.
In one use of the inventions, the everted stent may be used to stabilize a blockage such as a thrombus, while providing a perfusing path through the dilated thrombus. In another use, the stent may be positioned across a stenosed blood vessel region, and the region treated with a restenosis inhibiting agent. The restenosis inhibiting agent can be infused through the porous stent wall or reside on the stent itself and release into the vessel wall.
The present inventions can be used to accurately position the stent proximal end. The stent proximal end may be positioned accurately relative to a vessel ostium. The stent can be positioned near the proximal end of a stenosis located near or at an ostium. The everted stent can be advanced as previously discussed, until the proximal end is positioned at the desired location. The stent proximal end can be allowed to radially expand against the vessel walls. In some methods, the stent can be advanced further distally until the expanded proximal end is at the desired position. The stent placement may be followed using fluoroscopy. This desired position may be exactly at the ostium beginning, slightly within the ostium, or extending slightly from the ostium. The stent distal region can be released and allowed to expand. In this way, the stent proximal end can be positioned accurately relative to the ostium.
In one embodiment of the inventions, the elongate release member has a length of between about 100 cm. and 200 cm. In one embodiment, the outer diameter of the release member distal element is less than 2 mm. In various embodiments, the release member may be formed from stainless steel, Nitinol, polyimide, reinforced polymer, or PEEK and the like.
The delivery tube or shaft in some embodiments has a length of between about 75 cm. and 175 cm. The delivery tube can have an outside diameter of between about 6 Fr. and 1 Fr. In various embodiments of the inventions, the distal region of the delivery tube may be distally tapered. In some embodiments, the cross-sectional outer diameter of the delivery tube distal end is less than about 6 Fr. Delivery tubes can be made from flexible polymers such as PEBAX, nylon, polyester, polyurethane, polyethylene, FEP, Teflon, silicone, and the like, with or without reinforcement by metallic or polymeric elements. Microcatheters are well known to those skilled in the art and any suitably sized guide catheter or microcatheter may be used in combination with the present inventions, preferably about 3 Fr. or 4 Fr. in outer diameter. Some exemplary sized catheters that can be used with the present inventions are between about 75 cm. and 175 cm. in length. Guide or microcatheters useful in conjunction with the present inventions may be formed from Nylon, PEBAX, polyurethane, and the like. Guide catheters can be reinforced with metallic braids, with microcatheters preferably having very flexible distal end regions. The catheters can have a distal outer diameter of less than about 8 Fr. for guides and 4 Fr. for microcatheters.
This application is a continuation of U.S. application Ser. No. 13/614,035, filed Sep. 13, 2012, now U.S. Pat. No. 8,579,958, which is a continuation of U.S. application Ser. No. 12/477,613, filed Jun. 3, 2009, now U.S. Pat. No. 8,317,850, which is a divisional of U.S. application Ser. No. 11/035,671, filed Jan. 14, 2005, now abandoned, which is a continuation of U.S. application Ser. No. 10/096,628, filed Mar. 12, 2002, now U.S. Pat. No. 6,866,679. The entire contents of each of the foregoing applications and patents are incorporated herein by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
4655771 | Wallsten | Apr 1987 | A |
4723936 | Buchbinder et al. | Feb 1988 | A |
4877031 | Conway et al. | Oct 1989 | A |
4990151 | Wallsten | Feb 1991 | A |
5026377 | Burton et al. | Jun 1991 | A |
5318529 | Kontos | Jun 1994 | A |
5445646 | Euteneuer et al. | Aug 1995 | A |
5474563 | Myler et al. | Dec 1995 | A |
5484444 | Braunschweiler et al. | Jan 1996 | A |
5545209 | Roberts et al. | Aug 1996 | A |
5571135 | Fraser et al. | Nov 1996 | A |
5636641 | Fariabi | Jun 1997 | A |
5695499 | Helgerson et al. | Dec 1997 | A |
5702418 | Ravenscroft | Dec 1997 | A |
5725571 | Imbert et al. | Mar 1998 | A |
5776141 | Klein et al. | Jul 1998 | A |
5824041 | Lenker et al. | Oct 1998 | A |
5935161 | Robinson et al. | Aug 1999 | A |
5968053 | Revelas | Oct 1999 | A |
6077295 | Limon et al. | Jun 2000 | A |
6077297 | Robinson et al. | Jun 2000 | A |
6123723 | Konya et al. | Sep 2000 | A |
6126685 | Lenker et al. | Oct 2000 | A |
6149680 | Shelso et al. | Nov 2000 | A |
6152944 | Holman et al. | Nov 2000 | A |
6193739 | Chevillon et al. | Feb 2001 | B1 |
6251132 | Ravenscroft et al. | Jun 2001 | B1 |
6264683 | Stack et al. | Jul 2001 | B1 |
6350278 | Lenker et al. | Feb 2002 | B1 |
6371953 | Beyar et al. | Apr 2002 | B1 |
6383171 | Gifford et al. | May 2002 | B1 |
6387118 | Hanson | May 2002 | B1 |
6395008 | Ellis et al. | May 2002 | B1 |
6395017 | Dwyer et al. | May 2002 | B1 |
6419693 | Fariabi | Jul 2002 | B1 |
6425898 | Wilson et al. | Jul 2002 | B1 |
6428552 | Sparks | Aug 2002 | B1 |
6443971 | Boylan et al. | Sep 2002 | B1 |
6468298 | Pelton | Oct 2002 | B1 |
6517547 | Feeser et al. | Feb 2003 | B1 |
6562063 | Euteneuer et al. | May 2003 | B1 |
6576006 | Limon et al. | Jun 2003 | B2 |
6582460 | Cryer | Jun 2003 | B1 |
6602271 | Adams et al. | Aug 2003 | B2 |
6607551 | Sullivan et al. | Aug 2003 | B1 |
6669719 | Wallace et al. | Dec 2003 | B2 |
6699274 | Stinson | Mar 2004 | B2 |
6706055 | Douk et al. | Mar 2004 | B2 |
6764504 | Wang et al. | Jul 2004 | B2 |
6808529 | Fulkerson | Oct 2004 | B2 |
6815325 | Ishii | Nov 2004 | B2 |
6830575 | Stenzel et al. | Dec 2004 | B2 |
6843802 | Villalobos et al. | Jan 2005 | B1 |
6866679 | Kusleika | Mar 2005 | B2 |
6932837 | Amplatz et al. | Aug 2005 | B2 |
6960227 | Jones et al. | Nov 2005 | B2 |
6989024 | Hebert et al. | Jan 2006 | B2 |
7011675 | Hemerick et al. | Mar 2006 | B2 |
7074236 | Rabkin et al. | Jul 2006 | B2 |
7147656 | Andreas et al. | Dec 2006 | B2 |
7306624 | Yodfat et al. | Dec 2007 | B2 |
7357812 | Andreas et al. | Apr 2008 | B2 |
7371248 | Dapolito et al. | May 2008 | B2 |
7427288 | Sater | Sep 2008 | B2 |
7473271 | Gunderson | Jan 2009 | B2 |
7473272 | Pryor | Jan 2009 | B2 |
7572290 | Yodfat et al. | Aug 2009 | B2 |
7651520 | Fischell et al. | Jan 2010 | B2 |
7655031 | Tenne et al. | Feb 2010 | B2 |
7691138 | Stenzel et al. | Apr 2010 | B2 |
7717953 | Kaplan et al. | May 2010 | B2 |
7758624 | Dorn et al. | Jul 2010 | B2 |
7867267 | Sullivan et al. | Jan 2011 | B2 |
7942925 | Yodfat et al. | May 2011 | B2 |
7955370 | Gunderson | Jun 2011 | B2 |
7981148 | Aguilar et al. | Jul 2011 | B2 |
7993385 | Levine et al. | Aug 2011 | B2 |
8025692 | Feeser | Sep 2011 | B2 |
8034095 | Randolph et al. | Oct 2011 | B2 |
8042720 | Shifrin et al. | Oct 2011 | B2 |
8066754 | Malewicz | Nov 2011 | B2 |
8083791 | Kaplan et al. | Dec 2011 | B2 |
8092508 | Leynov et al. | Jan 2012 | B2 |
8097015 | Devellian | Jan 2012 | B2 |
8109987 | Kaplan et al. | Feb 2012 | B2 |
8133266 | Thomas et al. | Mar 2012 | B2 |
8147534 | Berez et al. | Apr 2012 | B2 |
8187314 | Davis et al. | May 2012 | B2 |
8257432 | Kaplan et al. | Sep 2012 | B2 |
8298276 | Ozawa et al. | Oct 2012 | B2 |
8317850 | Kusleika | Nov 2012 | B2 |
8366763 | Davis et al. | Feb 2013 | B2 |
8382818 | Davis et al. | Feb 2013 | B2 |
8579958 | Kusleika | Nov 2013 | B2 |
8591566 | Newell et al. | Nov 2013 | B2 |
8790387 | Nguyen et al. | Jul 2014 | B2 |
9072624 | Brown et al. | Jul 2015 | B2 |
20020029046 | Lorentzen Cornelius et al. | Mar 2002 | A1 |
20020049412 | Madrid et al. | Apr 2002 | A1 |
20020072789 | Hackett et al. | Jun 2002 | A1 |
20020138128 | Stiger et al. | Sep 2002 | A1 |
20030004539 | Linder et al. | Jan 2003 | A1 |
20030009208 | Snyder et al. | Jan 2003 | A1 |
20030050600 | Ressemann et al. | Mar 2003 | A1 |
20030135258 | Andreas | Jul 2003 | A1 |
20030208223 | Kleiner | Nov 2003 | A1 |
20030212410 | Stenzel et al. | Nov 2003 | A1 |
20040024416 | Yodfat et al. | Feb 2004 | A1 |
20040215331 | Chew | Oct 2004 | A1 |
20040220585 | Nikolchev | Nov 2004 | A1 |
20040230285 | Gifford, III | Nov 2004 | A1 |
20050096724 | Stenzel et al. | May 2005 | A1 |
20050119719 | Wallace et al. | Jun 2005 | A1 |
20050125051 | Eidenschink et al. | Jun 2005 | A1 |
20050143773 | Abrams et al. | Jun 2005 | A1 |
20050240254 | Austin | Oct 2005 | A1 |
20060036309 | Hebert et al. | Feb 2006 | A1 |
20060058865 | Case et al. | Mar 2006 | A1 |
20060074477 | Berthiaume et al. | Apr 2006 | A1 |
20060116750 | Hebert et al. | Jun 2006 | A1 |
20060184226 | Austin | Aug 2006 | A1 |
20060212042 | Lamport et al. | Sep 2006 | A1 |
20070027520 | Sherburne | Feb 2007 | A1 |
20070043430 | Stinson | Feb 2007 | A1 |
20070078504 | Mialhe | Apr 2007 | A1 |
20070088323 | Campbell et al. | Apr 2007 | A1 |
20070117645 | Nakashima | May 2007 | A1 |
20070203563 | Hebert et al. | Aug 2007 | A1 |
20070239254 | Chia et al. | Oct 2007 | A1 |
20070239261 | Bose et al. | Oct 2007 | A1 |
20070255388 | Rudakov et al. | Nov 2007 | A1 |
20070299500 | Hebert et al. | Dec 2007 | A1 |
20070299501 | Hebert et al. | Dec 2007 | A1 |
20070299502 | Hebert et al. | Dec 2007 | A1 |
20080015678 | Kaplan et al. | Jan 2008 | A1 |
20080027528 | Jagger et al. | Jan 2008 | A1 |
20080033528 | Satasiya et al. | Feb 2008 | A1 |
20080051705 | Von Oepen et al. | Feb 2008 | A1 |
20080071301 | Matsuura et al. | Mar 2008 | A1 |
20080077229 | Andreas et al. | Mar 2008 | A1 |
20080140180 | Dolan et al. | Jun 2008 | A1 |
20080147162 | Andreas et al. | Jun 2008 | A1 |
20080188865 | Miller et al. | Aug 2008 | A1 |
20080234795 | Snow et al. | Sep 2008 | A1 |
20080243225 | Satasiya et al. | Oct 2008 | A1 |
20080255653 | Schkolnik | Oct 2008 | A1 |
20080300667 | Hebert et al. | Dec 2008 | A1 |
20090082609 | Condado | Mar 2009 | A1 |
20090105802 | Henry et al. | Apr 2009 | A1 |
20090132019 | Duffy et al. | May 2009 | A1 |
20090138066 | Leopold et al. | May 2009 | A1 |
20090143849 | Ozawa et al. | Jun 2009 | A1 |
20090157048 | Sutermeister et al. | Jun 2009 | A1 |
20090204196 | Weber | Aug 2009 | A1 |
20090264985 | Bruszewski | Oct 2009 | A1 |
20090287292 | Becking et al. | Nov 2009 | A1 |
20090299449 | Styrc | Dec 2009 | A1 |
20090318947 | Garcia et al. | Dec 2009 | A1 |
20100049293 | Zukowski et al. | Feb 2010 | A1 |
20100049297 | Dorn | Feb 2010 | A1 |
20100057184 | Randolph et al. | Mar 2010 | A1 |
20100057185 | Melsheimer et al. | Mar 2010 | A1 |
20100069852 | Kelley | Mar 2010 | A1 |
20100087913 | Rabkin et al. | Apr 2010 | A1 |
20100094394 | Beach et al. | Apr 2010 | A1 |
20100198334 | Yodfat et al. | Aug 2010 | A1 |
20100204770 | Mas et al. | Aug 2010 | A1 |
20100262157 | Silver et al. | Oct 2010 | A1 |
20100268328 | Stiger | Oct 2010 | A1 |
20100274270 | Patel et al. | Oct 2010 | A1 |
20100298931 | Quadri et al. | Nov 2010 | A1 |
20100331951 | Bei et al. | Dec 2010 | A1 |
20110009943 | Paul et al. | Jan 2011 | A1 |
20110022157 | Essinger et al. | Jan 2011 | A1 |
20110029065 | Wood et al. | Feb 2011 | A1 |
20110034987 | Kennedy | Feb 2011 | A1 |
20110054586 | Mayberry et al. | Mar 2011 | A1 |
20110093055 | Kujawski | Apr 2011 | A1 |
20110098804 | Yeung et al. | Apr 2011 | A1 |
20110106235 | Haverkost et al. | May 2011 | A1 |
20110112623 | Schatz | May 2011 | A1 |
20110152760 | Parker | Jun 2011 | A1 |
20110178588 | Haselby | Jul 2011 | A1 |
20110190862 | Bashiri et al. | Aug 2011 | A1 |
20110190865 | McHugo et al. | Aug 2011 | A1 |
20110208292 | Von Oepen et al. | Aug 2011 | A1 |
20110288626 | Straubinger et al. | Nov 2011 | A1 |
20110319904 | Hollett et al. | Dec 2011 | A1 |
20120029607 | McHugo et al. | Feb 2012 | A1 |
20120035700 | Leanna et al. | Feb 2012 | A1 |
20120053681 | Alkhatib et al. | Mar 2012 | A1 |
20120059449 | Dorn et al. | Mar 2012 | A1 |
20120065660 | Ferrera et al. | Mar 2012 | A1 |
20120116494 | Leynov et al. | May 2012 | A1 |
20120123511 | Brown | May 2012 | A1 |
20120253447 | Hayasaka et al. | Oct 2012 | A1 |
20120316638 | Grad et al. | Dec 2012 | A1 |
20130085562 | Rincon et al. | Apr 2013 | A1 |
20130131775 | Hadley et al. | May 2013 | A1 |
20130172925 | Garcia et al. | Jul 2013 | A1 |
20130226276 | Newell et al. | Aug 2013 | A1 |
20130226278 | Newell et al. | Aug 2013 | A1 |
20130261730 | Bose et al. | Oct 2013 | A1 |
20130274859 | Argentine | Oct 2013 | A1 |
20130282099 | Huynh | Oct 2013 | A1 |
20130304185 | Newell et al. | Nov 2013 | A1 |
20140025150 | Lim | Jan 2014 | A1 |
20140031918 | Newell et al. | Jan 2014 | A1 |
20140148893 | Kusleika | May 2014 | A1 |
20140200648 | Newell et al. | Jul 2014 | A1 |
20150066129 | Nageswaran et al. | Mar 2015 | A1 |
20150066130 | Haggstrom et al. | Mar 2015 | A1 |
20150066131 | Luong et al. | Mar 2015 | A1 |
Number | Date | Country |
---|---|---|
102159157 | Aug 2011 | CN |
775470 | May 1997 | EP |
1637176 | Mar 2006 | EP |
1656963 | May 2006 | EP |
2 078 512 | Jul 2009 | EP |
2179258 | Mar 1987 | GB |
WO-9601591 | Jan 1996 | WO |
WO-0149212 | Jul 2001 | WO |
WO-0189619 | Nov 2001 | WO |
WO-2007095031 | Aug 2007 | WO |
WO-2007117645 | Oct 2007 | WO |
WO-2010027485 | Mar 2010 | WO |
WO-2010086320 | Aug 2010 | WO |
WO-2010123831 | Oct 2010 | WO |
WO-2010127838 | Nov 2010 | WO |
WO-2011014814 | Feb 2011 | WO |
WO-2011076408 | Jun 2011 | WO |
WO-2011095966 | Aug 2011 | WO |
WO-2011144351 | Nov 2011 | WO |
WO-2012040240 | Mar 2012 | WO |
WO-2012158152 | Nov 2012 | WO |
Entry |
---|
U.S. Appl. No. 13/553,855, filed Jul. 20, 2012. |
U.S. Appl. No. 13/664,547, filed Oct. 31, 2012. |
U.S. Appl. No. 13/950,950, filed Jul. 25, 2013. |
U.S. Appl. No. 14/040,510, filed Sep. 27, 2013. |
U.S. Appl. No. 14/040,501, filed Sep. 27, 2013. |
U.S. Appl. No. 14/040,489, filed Sep. 27, 2013. |
U.S. Appl. No. 14/040,516, filed Sep. 27, 2013. |
U.S. Appl. No. 14/042,423, filed Sep. 30, 2013. |
Covidien's Pipeline Embolization Device and Delivery System Product Description and Instructions for Use, Jun. 2010. |
Number | Date | Country | |
---|---|---|---|
20140148893 A1 | May 2014 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11035671 | Jan 2005 | US |
Child | 12477613 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13614035 | Sep 2012 | US |
Child | 14076448 | US | |
Parent | 12477613 | Jun 2009 | US |
Child | 13614035 | US | |
Parent | 10096628 | Mar 2002 | US |
Child | 11035671 | US |